• Predictors of Very Late Events After Percutaneous Mitral Valvuloplasty in Patients With Mitral Stenosis. Am J Cardiol. 2016;117:1978-84.
  • Patency of coronary side branches covered by an everolimus-eluting bioresorbable vascular scaffold: clinical outcomes and computed tomography scan follow-up. 2016;11: e1283-90.
  • Effect of New-Onset Left Bundle Branch Block after Transcatheter Aortic Valve Implantation (CoreValve) on Mortality, Frequency of Re-hospitalization, and Need for Pacemaker. Am J Cardiol 2016, (in press). DOI: 10.1016/j.amjcard.2016.07.057.  PII: S0002-9149(16)31327-3.
  • Bioresorbable Vascular Scaffold for the Treatment of Coronary Bifurcation Lesions: Immediate Results and 1-year Follow-up. Rev Esp Cardiol. 2016;69(6):554–562.
  • Structural Damage of Jailed Guidewire During the Treatment of Coronary Bifurcation Lesions A Microscopic Randomized Trial. J Am Coll Cardiol Intv 2016;9:1917–24.
  • Effects of Mitral Annulus Remodeling Following MitraClip Procedure on Reduction of Functional Mitral Regurgitation. Rev Esp Cardiol 2016; 69 (11): 1020–1025. pii: S1885-5857(16)30029-9. doi: 10.1016/j.rec.2016.04.003.
  • Predictors of Very Late Events After Percutaneous Mitral Valvuloplasty in Patients With Mitral Stenosis. Am J Cardiol. 2016 Jun 15;117(12):1978-84. doi: 10.1016/j.amjcard.2016.03.051. Epub 2016 Apr 6.
  • Clinical features and changes in epidemiology of infective endocarditis on pacemaker devices over a 27-year period (1987-2013). 2016 Jun;18(6):836-41. doi: 10.1093/europace/euv377. Epub 2015 Dec 24.
  • Effect of early treatment with ivabradine combined with beta-blockers versus beta-blockers alone in patients hospitalised with heart failure and reduced left ventricular ejection fraction (ETHIC-AHF): A randomised study. Int J Cardiol. 2016 Aug 15;217:7-11. doi: 10.1016/j.ijcard.2016.04.136. Epub 2016 Apr 19.
  • Implante de Mitraclip como terapia puente al transplante cardiaco. Mitraclip transcather mitral valve repair. 2016; 60-61.
  • Percutaneous Mitral Valve Repair for Acute Mitral Regurgitation After an Acute Myocardial Infarction. J Am Coll Cardiol. 2015 Jul 7;66(1):91-2. doi: 10.1016/j.jacc.2015.03.597.
  • Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry. 2015 May 5;131(18):1566-74. doi: 10.1161/CIRCULATIONAHA.114.014089. Epub 2015 Mar 9.
  • Stent Repair for Complex Coarctation of Aorta. JACC Cardiovasc Interv. 2015 Aug 24;8(10):1368-79. doi: 10.1016/j.jcin.2015.05.018. EDITORIAL COMMENT. Kenny DP, Hijazi ZM :Overcoming complexity. Stenting for aortic coarctation comes of age. JACC Cardiovasc Interv 2015;8:1380-1381.
  • Changes in Clinical Profile, Epidemiology and Prognosis of Left-sided Native-valve Infective Endocarditis Without Predisposing Heart Conditions. Rev Esp Cardiol 2015; 68 (5): 445-448.
  • Idiopathic Dilated Cardiomyopathy Treated With Intracoronary Infusion of Autologous Bone Marrow Cells: Long-term Follow-up. Rev Esp Cardiol. 2015;68:726-8.
  • Optical Coherence Tomography Evaluation of Late Strut Coverage Patterns Between First-Generation Drug-Eluting Stents and Everolimus-Eluting Stent. Catheter Cardiovasc Interv 2014; 84(5): 720-6. doi: 10.1002/ccd.25235. Epub 2013 Oct 31.2013.
  • Immediate Results and Long-Term Clinical Outcome of Patients With Unprotected Distal Left Main Restenosis The CORPAL (Córdoba and Las Palmas) Registry. J Am Coll Cardiol Intervent 2014; 7: 212-221. DOI: 10.1016/j.jcin.2013.06.017. Epub 2014 Jan 15.
  • Next-generation Transcatheter Aortic Valves. An Opportunity to Expand Therapeutic Indications?. Rev Esp Cardiol 2014; 67: 878-880. 10.1016/j.rec.2014.07.004. Epub 2014 Oct 3.
  • Do We Know How to Treat Bifurcation Coronary Lesions?. Rev Esp Cardiol 2014; 67(10): 790-3. doi: 10.1016/j.rec.2014.05.017.
  • Assessment of side branch predilation before a provisional T-stent strategy for bifurcation lesions. A randomized trial. Am Heart J 2014;168:374-80. doi: 10.1016/j.ahj.2014.05.014. Epub 2014 Jun 6.
  • Three-year Follow-up of Patients With Bifurcation Lesions Treated With Sirolimus- or Everolimus-eluting Stents: SEAside and CORpal Cooperative Study. Rev Esp Cardiol. 2014;67(10):797–803. Doi: 10.1016/j.rec.2013.10.016. Epub 2014 Feb 22. EDITORIAL COMMENT. Birgelen C, KG Houwelingen, Lama MK. “Coronary Bifurcations: Still the Touchstone of Drug-eluting Stents and Bioresorbable Vascular Scaffolds?”. Rev Esp Cardiol. 2014;67(10):787–789.
  • Percutaneous coronary intervention for coronary bifurcation disease: consensus from the first 10 years of the European Bifurcation Club meetings. 2014 Sep;10(5):545-60. doi: 10.4244/EIJV10I5A97.
  • Mitral Regurgitation During Transcatheter Aortic Valve Implantation: The Same Complication With a Different Mechanism. J Invasive Cardiol 2014;26(11):603-608. PMID: 25364002.
  • Initial Experience of Percutaneous Treatment of Mitral Regurgitation With MitraClipW Therapy in Spain. Rev Esp Cardiol. 2014;67(12):1007–1012. DOI: 10.1016/j.rec.2014.02.019. Epub 2014 Jun 21.
  • Functional Improvement in Patients With Dilated Cardiomyopathy After the Intracoronary Infusion of Autologous Bone Marrow Mononuclear Cells. Rev Esp Cardiol. 2013; 66: 450-457. pii: S0300-8932(13)00036-5. doi: 10.1016/j.recesp.2012.11.014.
  • Fenestration Closure After Fontan Surgery. Contributions of Percutaneous Interventionism. Rev Esp Cardiol. 2013; 66: 909-911. DOI: 10.1016/j.recesp.2013.05.018.
  • Monitoring complex secundum atrial septal defects percutaneous closure with real time three-dimensional echocardiography. Ecocardiography 2012; 29: 729-734.
  • Randomized study comparing everolimus and sirolimus eluting stents in patients with bifurcation lesions treated by provisional side-branch stenting. Catheter Cardiovasc Interv. 2012; 80:1165–1170. Doi: 10.1002/ccd.24281. EDITORIAL COMMENT. Diletti R, Serruys P. From First to Second Generation Drug Eluting Stents for Treatment of Coronary Bifurcations: Are We Making Progress?. Catheter Cardiovasc Interv 80: 1171–1172 (2012).
  • Usefulness of transesophageal echocardiography during implantation of the corevalve percutaneous aortic prosthesis: influence of the learning curve. Catheter Cardiovasc Interv 2012; 80:964–971. Jull 31. Doi: 10.1002/Ccd.23370. EDITORIAL COMMENT. Catheter Cardiovasc Interv 2012; 80: 972.
  • Early improvement of the regional and global ventricle function estimated by two-dimensional speckle tracking echocardiography after percutaneous aortic valve implantation. Echocardiography 2012; 30:37-44. Sep 18. Doi: 10.1111/j.1540-8175.2012.01808.x.
  • An electrocardiographic sign of tumor invasion of the myocardium. Am J Emergency Medicine 2012; 30 (9): 2078.e1-e5.
  • Etiologic spectrum and clinical features of mitral regurgitation in a spanish population. J Heart Valve Dis 2012; 21:293-8.
  • Prognostic impact of baseline low blood pressure in hypertensive patients with stable coronary artery disease of daily clinical practice. J Clin Hypertens (Greenwich) 2012;14:537-46.
  • Feasibility of bidimensional Speckle-Tracking echocardiography for strain analysis in consecutive patients in daily clinical practice. Echocardiography 2012; 29:923-926. Doi: 10.1111/J.1540-8175.2012.01739.X.
  • Coronary bifurcation lesions treated with simple approach (from the Cordoba & Las Palmas [CORPAL] kiss trial). Am J Cardiol 2011, 107: 1460-65.
  • Long-Term Outcome of Patients With Isolated Thin Discrete Subaortic Stenosis Treated by Balloon Dilation. A 25-Year Study. Circulation 2011; 124: 1461-68.
  • Measurement of aortic valve annulus using different cardiac imaging techniques in transcatheter aortic valve implantation: agreement with finally implanted prosthesis size. Echocardiography-J Cardiovasc Ultrasound Allied Tech 2011; 28: 388-396.
  • Ultrasound Study of the Prevalence of Plaque at the Carina in Lesions That Affect the Coronary Bifurcation: Implications for Treatment With Provisional Stent. Rev Esp Cardiol 2011; 64: 43-50.
  • Early Development of Leaks in the CoreValve Percutaneous Aortic Valve Prosthesis: Echocardiographic Assessment. Rev Esp Cardiol 2011; 64: 67-70.
  • Inverted Crush Technique for Uncrossable Side Branch Occlusion During Provisional Side Branch Stenting: a New Role for the Jailed Wire. Rev Esp Cardiol 2011; 64: 718-22.
  • Outcomes and safety of antithrombotic treatment in patients aged 80 years or older with nonvalvular atrial fibrillation. Am J Cardiol 2011; 107: 1489-1493.
  • Percutaneous Implantation of the CoreValve® Self-Expanding Aortic Valve Prosthesis in Patients With Severe Aortic Stenosis: Early Experience in Spain. Rev Esp Cardiol 2010; 63: 141-148. EDITORIAL COMMENT: John Webb. “Transcatheter Aortic Valve Implantation. Balancing Enthusiasm and Caution”. Rev Esp Cardiol 2010; 63: 131-3.
  • Prevalence of Patent Foramen Ovale Determined by Transesophageal Echocardiography in Patients With Cryptogenic Stroke Aged 55 Years or Older. Same as Younger Patients?. Rev Esp Cardiol 2010; 63 (3): 315-322.
  • Functional Recovery Following Intracoronary Infusion of Autologous Mononuclear Bone Marrow Cells in Patients With Chronic Anterior Myocardial Infarction and Severely Depressed Ventricular Function. Rev Esp Cardiol 2010; 63: 1127-35. EDITORIAL COMMENT: Terzic A, Perez-Terzic C. “Cell Therapy for Heart Failure”. Rev Esp Cardiol 2010; 63: 1117-19.
  • Use of the Venture Wire-Control Catheter for Accessing Side Branches During Provisional Stenting: An Option for Bifurcations With an Unfavorable Anatomy. Rev Esp Cardiol 2010; 63: 1487-91.
  • Oral Anticoagulation in Nonvalvular Atrial Fibrillation in Clinical Practice: Impact of CHADS(2) Score on Outcome. Cardiology 2010; 115: 200-204.
  • Combined percutaneous revascularization and cell therapy after failed repair of anomalous origin of left coronary artery from pulmonary artery. Cath Cardio Intervent 2009; 73: 833-837.
  • Vulnerable Carina Anatomy and Ostial Lesions in the Left Anterior Descending Coronary Artery After Floating-Stent Treatment. Rev Esp Cardiol 2009; 62: 1240-9. EDITORIAL COMMENT: Carlo Di Mario and Rosario Parisi.” Floating Stenting: Yet Another Technique of Bifurcational Stenting?. Rev Esp Cardiol 2009; 62: 1221-3.
  • Percutaneous Coronary Intervention in Bifurcation Lesions. Does Classification Aid Treatment Selection?. Rev Esp Cardiol. 2009;62(06):595-8.Vol. 62 Num.06 DOI: 10.1016/S1885-5857(09)72221-2. EDITORIAL COMMENT. Morton J Kern. Catheter Cardio Intervent 2008; 71: 184.
  • Percutaneous Closure of Patent Foramen Ovale in Young Patients With Cryptogenic Stroke: Long-Term Follow-Up. Rev Esp Cardiol 2008; 61(6): 640-3.
  • Ultrasound Findings During Percutaneous Treatment of Bifurcated Coronary Lesions. Rev Esp Cardiol 2008; 61(9): 930-5. EDITORIAL COMMENT: Javier Botas. Bifurcation Lesions: The Last Great Frontier for Coronary Interventions. Rev Esp Cardiol 2008; 61(9):911-913.
  • Monitoring Percutaneous Closure of Interatrial Communications: Viewing the Same Landscape Through Different Windows. Rev Esp Cardiol 2008, 61(5):451-453.
  • Cardiovascular events and restenosis following administration of G-CSF in acute myocardial infarction: Systematic Review of the literature and individual patient-data meta-analysis. Heart 2008; 94: 610-616.
  • Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis. BMJ 2008; 337; a1331.
  • Predicting Embolic Events in Patients With Nonvalvular Atrial Fibrillation: Evaluation of the CHADS2 Score in a Mediterranean Population. Rev Esp Cardiol. 2008;61(1):29-35.
  • Clinical Characteristics and Prognosis of Infective Endocarditis in Women. Rev Esp Cardiol. 2008;61(1):36-40.
  • Ultrasound Findings During Percutaneous Treatment of Bifurcated Coronary Lesions. Rev Esp Cardiol. 2008;61(9):930-5.
  • Drug-eluting stents for the treatment of bifurcation lesions: A randomized comparison between paclitaxel and sirolimus stents. Am Heart J 2007; 153: 15.e1-15.e7.
  • Regenerative Therapy in Patients with a Revascularized Acute Anterior Myocardial Infarction and Depressed Ventricular Function. Rev Esp Cardiol 2007; 60 (4): 357-65. EDITORIAL COMMENT: Sanchez P, Fernández-Avilés F. Stem-Cell Therapy Following Large Acute Myocardial Infarction. Rev Esp Cardiol 2007; 60 (4): 346-8.
  • Resultados del tratamiento de las lesiones en bifurcación con stents farmacoactivos. Papel de la ecografía intracoronaria. Rev Esp Cardiol 2007; 7: 49E-56E.
  • A meta-analysis of 16 randomized trials of sirolimus-eluting stents in patients with coronary artery disease. J Am Coll Cardiol 2007; 50: 1373-80.
  • Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007; 370: 937-48.
  • Percutaneous Transcatheter Closure of Ventricular Septal Defects Using an Amplatz Device. Rev Esp Cardiol 2006. 59: 510-4.
  • Anomalous Origin of the Left Coronary Artery From the Pulmonary Artery: Diagnosis by Transesophageal Echocardiography in an Infant. Rev Esp Cardiol 2006; 59 (7): 736.
  • A New Classification of Coronary Bifurcation Lesions. Rev Esp Cardiol 2006; 59: 183.
  • Transcatheter closure of perimenbranous ventricular septal defects using the Amplatzer membranous VSD. Occluder: Immediate and midterm results of an international registry. Cath Cardio Intervent:2006;68: 620-8.
  • Heart failure with preserved ejection fraction. Effect of etiology on prognosis. Rev Esp Cardiol. 2006;59(4):346-51.
  • Left main total occlusion treated with drug eluting stent. Rev Esp Cardiol. 2006;59(6):632-5.
  • Should angiotensin-converting enzyme inhibitors be continued over the long term in patients whose left ventricular ejection fraction normalizes after an episode of acute myocarditis?. Rev Esp Cardiol. 2006;59(11):1199-201.
  • Percutaneous interventions on severe coarctation of the aorta a 21-year experience. Pediatric Cardiology Today 2005; 26: 176-89.
  • Percutaneous Treatment of Atrial Septal Aneurysm. Rev Esp Cardiol 2005; 58: 222-6.
  • Effects of Stem-Cell Mobilization With Recombinant Human Granulocyte Colony Stimulating Factor in Patients With Percutaneously Revascularized Acute Anterior Myocardial Infarction. Esp. Cardiol 2005, 58: 253-61. EDITORIAL COMMENT; Felipe Prósper: “Regenerative Cell Therapy After Myocardial Infarction: Cells or Growth Factors?”. Rev. Esp. Cardiol 2005, 58: 238-40.
  • Interventional Cardiology. Where Are We and Where Are We Going From Here?. Rev Esp Cardiol 2005; 58: 290-300.
  • Six-Month Intravascular Ultrasound Follow-up of Coronary Bifurcation Lesions Treated With Rapamycin-Eluting Stents: Technical Considerations. Rev Esp Cardiol 2005;58: 1278-86. EDITORIAL COMMENT: Thierry Lefévere. “Bifucartion Lesions: The Simpler, the Better”. Rev Esp Cardiol 2005, 58; 1261-65.
  • Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease. JAMA 2005; 294: 819-825.COMENTARIO EDITORIAL. N Engl J Med, 2005;353:724-7.
  • Short- and Long-Term Prognosis of Infective Endocarditis in Non- Injection Drug Users: Improved Results Over 15 Years (1987–2001). Rev Esp Cardiol. 2005;58(10):1188-96.
  • Acute aortic insufficiency complicating stent treatment of supravalvular aortic stenosis: successful release of trapped leaflets by wiring the stent. Catheter Cardio Intervent 2004; 61: 537-541. EDITORIAL COMMENT. Charles E Mullins. Catheter Cardio Intervent:2004;61: 542.
  • Rapamycin-Eluting stents for the treatment of unprotected left main coronary disease. Am Heart J 2004; 148: 481-5.
  • Rapamycin-eluting stents for the treatment of bifurcated coronary lesions. A randomized comparision of a simple versus complex strategy. Am Heart J 2004; 148: 857-64.
  • Percutaneous treatment of coarctation of the aorta. Pediatric Cardiology Today 2004; 2: 3-4.
  • Short-term results with the Ross procedure. Does the etiology of aortic valvulopathy affect the outcome?. Rev Esp Cardiol 2004;57(6):531-7.
  • Influence of stent treatment strategies in the long-term outcome of patients with long diffuse coronary lesions. Catheter Cardio Intervent 2003; 58:293-300.
  • Successful stent ablation with rotational atherectomy. Catheter Cardio Intervent 2003; 60: 501-504.
  • Late Recovery of Coronary Flow Reserve in Patients Successfully Treated with a Percutaneous Procedure. Esp Cardiol 2003; 56(5):459-64. II PREMIO IZASA.
  • Prevalence of patent foramen ovale in young patients with cryptogenic stroke. Rev Esp Cardiol 2003;56(7):662-8.
  • Percutaneous Closure of Large Atrial Septal Defects. Rev Esp Cardiol 2003; 56: 888-893.
  • A stepwise strategy for the stent treatment of bifurcated coronary lesions. Catheter Cardio Intervent 2002; 55:50-57.
  • Percutaneous cardiopulmonary ssupport in critical patients needing coronary interventions with stents. Catheter Cardio Intervent 2002; 57: 467-475.
  • Effectiveness of percutaneous device occlusion for atrial septal defect in adult patients with pulmonary hypertension. Am Heart J 2002; 144:877-880.
  • Impact of final coronary flow velocity reserve on late outcome following stent implantation. Eur Heart J 2002; 23: 331-340. COMENTARIO EDITORIAL: Epicardial versus microcirculatory dissociation. Eur Heart J 2002; 23: 274-276.
  • Predictors of restenosis following unprotected left-main coronary stenting. Am J Cardiol 2001; 88:.308-310.
  • Platypnea-Orthodeoxia due to Aortic Elongation. Circulation 2001;104:741.
  • Differential characteristics of infective endocarditis in children. Rev Esp Cardiol 2001; 54: 111-113. PMID: 11141462.
  • Percutaneous balloon expandable stents for sealing of acute aortic dissection. Tex Heart Inst J 2000;27:281-5.
  • Transcatheter occlusion of complex atrial septal defects. Catheter Cardio Intervent 2000; 51: 33-41.
  • Results of Transvenous Occlusion of Secundum Atrial Septal Defects With the Fourth Generation Buttoned Device: Comparision With First, Second and Third Generation Devices. J Am Coll Cardiol 2000;36: 583-592.
  • Randomized Comparision of Elective Stent Implantation and Coronary Ballon Angioplasty Guided by Online Quentitative Angiography and Intracoronary Doppler. Circulation 2000;102:2938-2944. COMENTARIO EDITORIAL: Circulation 2000;102:2910-14.
  • Combined Percutaneous Atrial Septal Defect Occlusion and Pulmonary Balloon Valvuloplasty. Tex Heart Inst J 2000; 27:216-7.
  • Immediate and follow-up findings after stent treatment for severe coarctation of aorta. Am J Cardiol 1999; 83:400-406.
  • Simple and complex stent strategies for bifurcated coronary arterial stenosis involving the side branch origin. Am J Cardiol 1999; 83:1320-1325.
  • Angioplastia coronaria: ¿stent siempre en arterias de más de 2,5 mm? Argumentos a favor. Rev Esp Cardiol 1999; 52: 79-84.
  • Angiographic predictors of neointimal thickening after successful coronary wall healing following percutaneous revascularization. Am Heart J 1997; 133: 210-22.COMENTARIO EDITORIAL en “Cardiology 1998″, Willians C Roberts editor, Butterworth-Heinemann, Boston 1998:226.
  • Obliteration of femoral pseudoaneurysm complicating coronary intervention by direct puncture and permanent or removable coil insertion. Am J Cardiol 1997; 80: 786-788.
  • In-Laboratory Removal of Femoral Sheath Following Protamine Administration in Patients Having Intracoronary Stent Implantation. Am J Cardiol 1997; 80: 1336-1338.
  • Tailored stent treatment for severe supravalvular aortic stenosis. Am J Cardiol 1996; 78:1081-1083.
  • Reduction of thrombotic and hemorrhagic complications after stent implantation. Am Heart J 1996; 132:1119-1126.
  • Follow-up patency of side branches covered by an intracoronary Palmaz-Schatz stent. Am Heart J 1995; 129: 436-440.
  • Balloon-expandable stent repair of severe coarctation of aorta. Am Heart J 1995;129:1002-1008. COMENTARIO EDITORIAL en Year Book of Cardiology 1996:380-382.
  • Effectiveness of coronary stenting for the treatment of chronic total occlusion in angina pectoris. Am J Cardiol 1994; 73: 1222-1224.
  • Strategies on the treatment of thin discrete subaortic stenosis. J Am Coll Cardiol 1993; 21: 1303-1304.
  • Serial angiographic observations after successful directional coronary atherectomy. Am Heart J 1993; 125: 1217-1220.
  • Factors determining late success after mitral balloon valvulotomy. Am J Cardiol 1993; 71: 1181-5.
  • Intracoronary ultrasound assesment of directional coronary atherectomy: Immediate and follow-up findings. J Am Coll Cardiol 1993; 21: 298-307.
  • Sequential transcatheter treatment of combined coarctation of aorta and persistent ductus arteriosus. Am Heart J 1992; 123: 249-250.
  • Ballon valvuloplasty for mild mitral stenosis. Catheter Cardiovasc Intervent 1992; 25: 343-344.
  • Peripheral stent recovery after failed intracoronary delivery. Catheter Cardio Intervent 1992; 27: 230-233.
  • Divided Palmaz-Schatz stent for discrete coronary stenosis. J Invas Cardiol 1992; 4: 389-392.
  • Balloon valvuloplasty for mild mitral stenosis. Catheter Cardio Intervent 1991; 24: 1-5.
  • Immediate and Follow-Up Results of Transluminal Balloon Dilation For Discrete Subaortic Stenosis. J Am Coll Cardiol 1991; 18: 1309-1315. COMENTARIO EDITORIAL: Ritter SD. Discrete subaortic stenosis and balloon dilation: the four questions revisited. J Am Coll Cardiol 1991; 18: 1316. COMENTARIO EDITORIAL en “Cardiology 1992” William C Roberts Editor, Butterworth-Heinemann, Boston 1992, Pg 387.
  • Cardiac tamponade complicating mitral balloon valvuloplasty. Am J Cardiol 1991; 68: 802-805.
  • Transarterial mitral valvuloplasty in conditions of acute pulmonary edema. Am Heart J 1990; 119: 1416-1419.
  • Factors influencing progression of mitral regurgitation after transarterial balloon valvuloplasty for mitral stenosis. Am J Cardiol 1990; 66: 737-740.
  • Balloon valvuloplasty for mitral restenosis after previous surgery: a comparative study. Am Heart J 1990; 120: 568-571.
  • Aberrant right subclavia artery associated with common carotid trunk rare cause of vascular ring. Eur J Cardiothorac Surg. 1990; 4 (10): 568-70.
  • Angiographic follow up after balloon angioplasty for coarctation of the aorta. J Am Coll Cardiol 1989; 13: 689-695. COMENTARIO EDITORIAL en el mismo volumen p: 696-699. COMENTARIO EDITORIAL en Cardiología 1989;4:216.
  • Abrupt homeostatic responses to transient intracardiac occlusion during balloon valvuloplasty. Am J Cardiol 1989; 64: 491-497.
  • Physiopathology of transient ventricular occlusion during balloon valvuloplasty for pulmonic or aortic stenosis”. Am J Cardiol 1988; 61: 436-440.
  • Assessment of Bjork-Shiley and porcine mitral valve dysfunction by M-mode echocardiographic left ventricular dimension. Tex Heart Ins J 1987; 14: 72-76.
  • Two level left ventricular outflow dilatation: Sequential therapeutic approach. Am Heart J 1987; 114: 162-165.
  • Effects of acute changes in load and inotropic state on the exponential rate of fiber shortening and other indices of myocardial contractility in the anesthetized intact dog. Can J Physiol Pharmacol 1.987; 65: 46-53.
  • Percutaneous transluminal balloon dilatation for discrete subaortic stenosis”. Am J Cardiol 1986;58:619-621. COMENTARIO EN CARDIOLOGY 1987. Roberts WC. Editorial Yorke Medical Books. p:386.
  • Transluminal extraction of intracardiac foreign bodies using a deflecting guide. Rev Esp Cardiol. 1986 May-Jun;39(3):244-6.
  • Percutaneous transluminal angioplasty of stenotic ductus arteriosus”. Catheter Cardio Intervent 1985; 11: 493-500.
  • Transluminal valvuloplasty in pulmonary stenosis. Rev Esp Cardiol. 1985 May-Jun;38(3):213-7.
  • Contrast bidimensional echocardiography in the morphologic and functional post operative evaluation of the Senning technique for complete transposition of the great vessels. Am Heart J 1984; 108: 110-115.
  • Percutaneous transluminal angioplasty for aortic isthmic coarctation in infancy. Am J Cardiol 1984 (8); 54: 1147-1149.
  • Congenitally corrected transposition in a patient with situs inversus, atrioventricular discordance and mesocardias {IDD}. Tex Heart Inst J 1983; 10 (3), 293-298.
  • The exponential rate of fiber shortening. A new angiographic measurement of left ventricular contractily in man. Eur J Cardiol 1981; 12: 333-355. Premio Cruz Auñón.
  • The ascending slope of the apex-cardiogram. Its relationships with angiographic determination of left ventricular function. Eur J Cardiol 1978; 7/2-3: 219-237.
  • Hemodynamic and angiographic changes following nitroglycerine in coronary artery disease. Eur J Cardiol 1977; 5/4: 357-372.
  • Opacification of a coronary vein in left ventricular angiography. Tex Heart I J 1977; 4: 416-421.
  • Echographic Pseudo-IHSS patern of the mitral valve in severe aortic insuficiency. Tex Heart I J 1976; 3: 228-232.
  • Quantitative assessment of left ventricular asynergy. Tex Heart I J 1976; 3: 394-407.
  • Simplified graphic method for calculation of stenotic valve areas. Tex Heart I J 1975; 2: 105-106.
  • Quantitative Segmental analysis of contractily in the prolapsed mitral valve syndrome measured by ejection indices. Tex Heart I J 1975; 2: 236-250.
  • Vectocardiography in Tetralogy of Fallot before and after operation. Palliative and corrective Surgery. Chest 1.975; 68: 548-553. COMENTARIO EDITORIAL: Waldo A. Limitations of electrocardiograms. Chest 1975; 68: 482-483.

Pin It on Pinterest

Share This